Bodyport Overview

  • Founded

  • 2015

Founded
  • Status

  • Private

  • Employees

  • 23

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $11.2M

  • Investors

  • 10

Bodyport General Information

Description

Operator of a biomarker platform intended to detect early signs of cardiovascular disease. The company's platform with the help of proprietary sensor technology detects cardiac signals and biomarkers through a user's feet, powering algorithms that have the potential to predict risk, enabling care teams to assess the overall health status of their patients and better predict, understand, and intervene in worsening health to prevent hospitalizations and improve quality of life.

Contact Information

Website
www.bodyport.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Primary Office
  • 970 Folsom Street
  • San Francisco, CA 94107
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bodyport Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 11-Aug-2020 $11.2M 000.00 000.00 Completed Generating Revenue
2. Seed Round 01-Apr-2018 00.000 00.00 000.00 Completed Generating Revenue
1. Accelerator/Incubator 18-Aug-2015 $120K $120K 00.000 Completed Generating Revenue
To view Bodyport’s complete valuation and funding history, request access »

Bodyport Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed 4,941,976 $0.000010 $0.06 $0.93 $0.93 1x $9.28 2.44%
To view Bodyport’s complete cap table history, request access »

Bodyport Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biomarker platform intended to detect early signs of cardiovascular disease. The company's platform with t
Decision/Risk Analysis
San Francisco, CA
23 As of 2023
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000 000000000
Mountain View, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
0000000000 000000000
Campbell, CA
00 As of 0000
00.000
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bodyport Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AliveCor Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
00000000000000000 Venture Capital-Backed Campbell, CA 00 00.000 00000000000 00.000
You’re viewing 2 of 2 competitors. Get the full list »

Bodyport Patents

  • 13

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 5

    Pending

  • 000

    Expiring in next 12 mo

Bodyport Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D883118-S1 Bioelectrical signal and weight measuring device Active 21-Dec-2018 0
CA-3116856-A1 Cardiovascular signal acquisition, fusion, and noise mitigation Pending 17-Oct-2018 0000000000
EP-3866677-A1 Cardiovascular signal acquisition, fusion, and noise mitigation Pending 17-Oct-2018 0000000000
EP-3866677-A4 Cardiovascular signal acquisition, fusion, and noise mitigation Pending 17-Oct-2018 0000000000 0
CA-3116846-A1 Cardiovascular signal acquisition, fusion, and noise mitigation Pending 17-Oct-2018 A61B5/7203
To view Bodyport’s complete patent history, request access »

Bodyport Executive Team (5)

Name Title Board Seat Contact Info
John Lipman Chief Executive Officer
Corey Centen Co-Founder, Chief Technology Officer, President & Board Member
Debbie Lin Ph.D Executive Director
Sarah Smith Co-Founder, Chief Product Officer & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Bodyport Board Members (7)

Name Representing Role Since
Bruce Leak Playground Global Board Member 000 0000
Corey Centen Bodyport Co-Founder, Chief Technology Officer, President & Board Member 000 0000
Garry Tan Initialized Capital Management Board Member 000 0000
Jim Pursley Self Board Member 000 0000
Phyllis Whiteley Ph.D Self Chairman of the Board 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Bodyport Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bodyport Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Regah Ventures Venture Capital Minority 000 0000 000000 0
Beth McClendon Angel (individual) Minority 000 0000 000000 0
Boehringer Ingelheim Venture Fund Venture Capital Minority 000 0000 000000 0
HCVC Venture Capital Minority 000 0000 000000 0
Initialized Capital Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial